Literature DB >> 20801569

Reducing the incidence of pseudohyperkalemia by avoiding making a fist during phlebotomy: a quality improvement report.

Masanori Seimiya1, Toshihiko Yoshida, Yuji Sawabe, Kazuyuki Sogawa, Hiroshi Umemura, Kazuyuki Matsushita, Fumio Nomura.   

Abstract

BACKGROUND: Pseudohyperkalemia is uncommon, but important. Local release of potassium caused by contraction of the forearm muscles from a tightly clenched fist or repeated fist clenching during phlebotomy is a recognized cause of pseudohyperkalemia. We investigated the use of a standard protocol to avoid fist clenching during phlebotomy. STUDY
DESIGN: Quality improvement report. SETTING & PARTICIPANTS: In 7 healthy volunteers, 10 blood samples were collected over 10-second intervals after 20 repeated fist clenching and unclenching movements. In 86 healthy volunteers, 3 blood samples were collected with and without prior fist clenching. Between September 1, 2006, and June 30, 2007, peripheral venous blood samples were collected from 73,846 outpatients at Chiba University Hospital without a protocol to avoid fist clenching. Between July 1, 2007, and March 31, 2009, blood samples were collected from 171,053 outpatients using the protocol. QUALITY IMPROVEMENT PLAN: After July 1, 2007, blood samples were collected from the basilic or cephalic vein without making a fist or by making a fist using minimal gripping strength. Also, when multiple specimens were obtained from 1 patient, the specimen for measuring serum electrolytes was obtained after the other specimens. OUTCOMES & MEASUREMENTS: Pseudohyperkalemia, defined as unexplained serum potassium level ≥6.5 mmol/L.
RESULTS: In the 7 volunteers, the decrease in serum potassium levels after cessation of fist clenching ranged from 8.4%-25.9%. In the 86 volunteers, the percentage with a decrease in serum potassium level ≥0.2 mmol/L between the first and third samples was 25.6% versus 6.7% with or without prior fist clenching, respectively. In clinical practice, we observed 8 cases of pseudohyperkalemia before implementing the protocol (0.0081%) and 1 case (0.00058%) after implementing the protocol (P = 0.001). LIMITATIONS: Causes of hyperkalemia before using precautions were assessed using retrospective analyses.
CONCLUSIONS: Avoiding fist clenching during phlebotomy and not using the first specimen for electrolyte measurements when obtaining multiple specimens from a single patient can reduce the occurrence of pseudohyperkalemia. Crown
Copyright © 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801569     DOI: 10.1053/j.ajkd.2010.06.014

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  Phlebotomy, a bridge between laboratory and patient.

Authors:  Cristiano Ialongo; Sergio Bernardini
Journal:  Biochem Med (Zagreb)       Date:  2016       Impact factor: 2.313

2.  A case of severe pseudohyperkalaemia due to muscle contraction.

Authors:  Jan Van Elslande; Toon Dominicus; Jaan Toelen; Glynis Frans; Pieter Vermeersch
Journal:  Biochem Med (Zagreb)       Date:  2020-06-15       Impact factor: 2.313

3.  Order of draw of blood samples affect potassium results without K-EDTA contamination during routine workflow.

Authors:  Şerif Ercan; Bahri Ramadan; Ozan Gerenli
Journal:  Biochem Med (Zagreb)       Date:  2021-04-15       Impact factor: 2.313

4.  Differentiating Pseudohyperkalemia From True Hyperkalemia in a Patient With Chronic Lymphocytic Leukemia and Diverticulitis.

Authors:  John Dewey; Joshua Mastenbrook; Laura D Bauler
Journal:  Cureus       Date:  2020-08-17

Review 5.  Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.

Authors:  Gregor Lindner; Emmanuel A Burdmann; Catherine M Clase; Brenda R Hemmelgarn; Charles A Herzog; Jolanta Małyszko; Masahiko Nagahama; Roberto Pecoits-Filho; Zubaid Rafique; Patrick Rossignol; Adam J Singer
Journal:  Eur J Emerg Med       Date:  2020-10       Impact factor: 4.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.